Considering the relationship of EGFR with angiogenesis, we hypothesized that GDF15 secreted from chemotherapy damage to tumor cells could promote neo‐angiogenesis after TACE treatment, eventually leading to the residual tumor progression. This evidence concerns the gene GDF15 and neoplasm.